Inhaled corticosteroids and growth: Still an issue after all these years

Journal of Pediatrics

Volumn 166, Issue 2, 2015, Pages 463-469

  Allen, David B ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; CORTICOSTEROID;

CATCH UP GROWTH; CHILD GROWTH; DRUG BIOAVAILABILITY; GROWTH INHIBITION; HUMAN; NOTE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC CIRCULATION; ASTHMA; CHILD; DRUG EFFECTS; GROWTH; PRACTICE GUIDELINE; PRESCHOOL CHILD;

ADRENAL CORTEX HORMONES; ASTHMA; CHILD; CHILD, PRESCHOOL; GROWTH; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84921507797     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.09.055     Document Type: Note

References (52)

1. G.A. Hollman, and D.B. Allen Overt glucocorticoid excess due to inhaled corticosteroid therapy Pediatrics 81 1988 452 455
2. D.G. Tinkelman, C.E. Reed, H.S. Nelson, and K.P. Offord Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children Pediatrics 92 1993 64 77
3. F.E. Simons A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group N Engl J Med 337 1997 1659 1665
4. A.A. Verberne, C. Frost, R.J. Roorda, H. van der Laag, and K.F. Kerrebijn One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group Am J Respir Crit Care Med 156 3 Pt 1 1997 688 695
5. D.B. Allen, E.A. Bronsky, C.F. LaForce, R.A. Nathan, D.G. Tinkelman, and M.L. Vandewalker Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group J Pediatr 132 3 Pt 1 1998 472 477
6. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group N Engl J Med 343 2000 1054 1063
7. T.W. Guilbert, D.T. Mauger, D.B. Allen, R.S. Zeiger, R.F. Lemanske Jr., and S.J. Szefler Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone J Allergy Clin Immunol 128 2011 956 963.e1-7
8. A.L. Fuhlbrigge, and H.W. Kelly Inhaled corticosteroids in children: effects on bone mineral density and growth Lancet Respir Med 2 2014 487 496
9. H.W. Kelly, A.L. Sternberg, R. Lescher, A.L. Fuhlbrigge, P. Williams, and R.S. Zeiger Effect of inhaled glucocorticoids in childhood on adult height N Engl J Med 367 2012 904 912
10. D.B. Allen Influence of inhaled corticosteroids on growth: a pediatric endocrinologist's perspective Acta Paediatr 87 1998 123 129
11. D.B. Allen, L. Bielory, H. Derendorf, R. Dluhy, G.L. Colice, and S.J. Szefler Inhaled corticosteroids: past lessons and future issues J Allergy Clin Immunol 112 3 Suppl 2003 S1 S40
12. C.L. Smith, and W. Kreutner In vitro glucocorticoid receptor binding and transcriptional activation by topically active glucocorticoids Arzneimittelforschung 48 1998 956 960
13. H.W. Kelly Comparison of inhaled corticosteroids: an update Ann Pharmacother 43 2009 519 527
14. R.A. Pauwels, S. Pedersen, W.W. Busse, W.C. Tan, Y.Z. Chen, and S.V. Ohlsson Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial Lancet 361 2003 1071 1076
15. C. Leach, G.L. Colice, and A. Luskin Particle size of inhaled corticosteroids: does it matter? J Allergy Clin Immunol 124 6 Suppl 2009 S88 S93
16. A.E. Mackie, J.E. McDowall, P. Ventresca, A. Bye, C. Falcoz, and P.T. Daley-Yates Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant Clin Pharmacokinet 39 Suppl 1 2000 17 22
17. C.L. Leach Improved delivery of inhaled steroids to the large and small airways Respir Med 92 Suppl A 1998 3 8
18. C.L. Leach, P.J. Davidson, B.E. Hasselquist, and R.J. Boudreau Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers Chest 122 2002 510 516
19. W.W. Busse, S. Brazinsky, K. Jacobson, W. Stricker, K. Schmitt, and J. Vanden Burgt Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant J Allergy Clin Immunol 104 1999 1215 1222
20. L.I. Harrison, G.L. Colice, D. Donnell, I. Soria, and R. Dockhorn Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study J Pharm Pharmacol 51 1999 263 269
21. F.D. Martinez, V.M. Chinchilli, W.J. Morgan, S.J. Boehmer, R.F. Lemanske Jr., and D.T. Mauger Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial Lancet 377 2011 650 657
22. R.N. Brogden, and D. McTavish Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis Drugs 44 1992 375 407
23. R.J. Martin, S.J. Szefler, V.M. Chinchilli, M. Kraft, M. Dolovich, and H.A. Boushey Systemic effect comparisons of six inhaled corticosteroid preparations Am J Respir Crit Care Med 165 2002 1377 1383
24. C.L. Leach, P.J. Kuehl, R. Chand, L. Ketai, J.P. Norenberg, and J.D. McDonald Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients Ann Allergy Asthma Immunol 108 2012 195 200
25. P.T. Daley-Yates, A.C. Price, J.R. Sisson, A. Pereira, and N. Dallow Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man Br J Clin Pharmacol 51 2001 400 409
26. H. Derendorf Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety Respir Med 91 Suppl A 1997 22 28
27. H. Bisgaard, D. Allen, J. Milanowski, I. Kalev, L. Willits, and P. Davies Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing Pediatrics 113 2004 e87 e94
28. K. Blake, R. Mehta, T. Spencer, R.L. Kunka, and L. Hendeles Bioavailability of inhaled fluticasone propionate via chambers/masks in young children Eur Respir J 39 2012 97 103
29. L. Thorsson, O. Borga, and S. Edsbacker Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder Br J Clin Pharmacol 47 1999 619 624
30. W.R. Lumry A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis J Allergy Clin Immunol 104 4 Pt 1 1999 S150 S158
31. P.T. Daley-Yates, and R.C. Baker Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations Br J Clin Pharmacol 51 2001 103 105
32. P.T. Daley-Yates, R.L. Kunka, Y. Yin, S.M. Andrews, S. Callejas, and C. Ng Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays Eur J Clin Pharmacol 60 2004 265 268
33. D.P. Skoner, G.S. Rachelefsky, E.O. Meltzer, P. Chervinsky, R.M. Morris, and J.M. Seltzer Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate Pediatrics 105 2000 e23
34. D.P. Skoner, D. Gentile, B. Angelini, R. Kane, D. Birdsall, and D. Banerji The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis Ann Allergy Asthma Immunol 90 2003 56 62
35. S. Weinstein, P. Qaqundah, G. Georges, and A. Nayak Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double- blind, placebo-controlled study with an open-label extension Ann Allergy Asthma Immunol 102 2009 339 347
36. D.B. Allen Systemic effects of intranasal steroids: an endocrinologist's perspective J Allergy Clin Immunol 106 4 Suppl 2000 S179 S190
37. R. Perou, R.H. Bitsko, S.J. Blumberg, P. Pastor, R.M. Ghandour, and J.C. Gfroerer Mental health surveillance among children - United States, 2005-2011 MMWR Morb Mortal Wkly Rep 62 Suppl 2 2013 1 35
38. B.L. Negrao, and M. Viljoen Stimulants and growth in children with attention-deficit/hyperactivity disorder Med Hypotheses 77 2011 21 28
39. N. Weintrob, D. Cohen, Y. Klipper-Aurbach, Z. Zadik, and Z. Dickerman Decreased growth during therapy with selective serotonin reuptake inhibitors Arch Pediatr Adolesc Med 156 2002 696 701
40. Methylphenidate growth retardation Prescrire Int 20 2011 238 239
41. T. Dura-Trave, M.E. Yoldi-Petri, F. Gallinas-Victoriano, and P. Zardoya-Santos Effects of osmotic-release methylphenidate on height and weight in children with attention-deficit hyperactivity disorder (ADHD) following up to four years of treatment J Child Neurol 27 2012 604 609
42. A. Poulton, and C.T. Cowell Slowing of growth in height and weight on stimulants: a characteristic pattern J Paediatr Child Health 39 2003 180 185
43. H. Zhang, M. Du, and S. Zhuang Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD Neuropediatrics 41 2010 55 59
44. M.C. Lisska, and S.A. Rivkees Daily methylphenidate use slows the growth of children: a community-based study J Pediatr Endocrinol Metab 16 2003 711 718
45. J.M. Swanson, G.R. Elliott, L.L. Greenhill, T. Wigal, L.E. Arnold, and B. Vitiello Effects of stimulant medication on growth rates across 3 years in the MTA follow-up J Am Acad Child Adolesc Psychiatry 46 2007 1015 1027
46. A. Charach, M. Figueroa, S. Chen, A. Ickowicz, and R. Schachar Stimulant treatment over 5 years: effects on growth J Am Acad Child Adolesc Psychiatry 45 2006 415 421
47. J. Biederman, T.J. Spencer, M.C. Monuteaux, and S.V. Faraone A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects J Pediatr 157 2010 635 640 640.e1
48. T.J. Spencer, S.V. Faraone, J. Biederman, M. Lerner, K.M. Cooper, and B. Zimmerman Does prolonged therapy with a long-acting stimulant suppress growth in children with ADHD? J Am Acad Child Adolesc Psychiatry 45 2006 527 537
49. L. Agertoft, and S. Pedersen Effect of long-term treatment with inhaled budesonide on adult height in children with asthma N Engl J Med 343 2000 1064 1069
50. C.G. Brook Short stature never killed anybody J Pediatr 133 1998 591 592
51. National Asthma Education and Prevention Program Expert Panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma - summary report 2007 J Allergy Clin Immunol 120 5 Suppl 2007 S94 S138
52. D.B. Allen, J.R. Julius, T.J. Breen, and K.M. Attie Treatment of glucocorticoid-induced growth suppression with growth hormone. National Cooperative Growth Study J Clin Endocrinol Metab 83 1998 2824 2829